Publications

Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000. A pooled analysis of magnetic fields, wire codes and childhood leukemia. Epidemiol 227(2):294–306.

Frankenfeld C, Taren D. 2000. HIV and infant growth. In: Watson R (ed), Nutrition and AIDS, 2nd edition. CRC Press, Boca Raton, Florida, ISBN: 97881420042290.

Choksi NY, Nix WB, Wyrick SD, Booth RG. 2000. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain. Brain Research 852(1):151–160; doi: 10.1016/s0006-8993(99)02228-3.

Choksi NY, Nix WB, Wyrick SD, Booth RG. Phenylaminotetralins activate histamine H1 receptors to stimulate dopamine synthesis in vivo in rat brain. Poster presented at the Receptor Chemistry Towards the Third Millennium – 12th Camerino-Noordwijkerhout Symposium, 1999.

Haws L. Permitting of hazardous waste combustion facilities in the state of Texas: Risk assessment procedures and status update. Presented at the Texas Chemical Council Quarterly Meeting. Houston, TX, September 1999.

Clewell HJ, Gearhart JM, Gentry PR, Covington TR, Van Landingham CB, Crump KS, and Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19:541–552.

Rish W, Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.

Cyr PL, Malloy D. 1999. Patient satisfaction and physician profiling. In: Lynman K, Piland N (eds) Physician Profiling: A Source Book for Health Care Administrators. Jossey-Bass Health Series, San Francisco. pp. 121-136.

Trippodo NC, Fox M, Monticello TM, Panchal BC, Asaad MM. 1999. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril. J Cardiovasc Pharmacol 34(6):782-790; doi: 10.1097/00005344-199912000-00003.

Casale RA, Jensen IS, Egholm M. 1999. Synthesis of PNA oligomers by Fmoc chemistry. In Peptide Nucleic Acids: Protocols & Applications. Weymondham, UK: Horizon Scientific Press.

McNamara JF, Lombardo H, Pillai SK, Jensen IS, Kates SA. A comparison of solid-phase techniques for the construction of chemokines. In Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Segal BM, McNamara JF, Jensen IS, Kates SA, Holm RH. Design and synthesis of cyclic peptides for iron-sulfur cluster assembly and encapsulation. In: Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Zucker RM, Hunter ES III, Rogers JM. 1999. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18(4):473–480; doi: 10.1006/meth.1999.0815.

Parvathy S, Choksi N, Fang Y, Sabo SL, Buxbaum JD. Characterization of multipartite complexes of APP. Poster presented at Society for Neuroscience Annual Meeting, 1999

Lilliehook C, Choksi NY, Hof P, Choi EK, Zaidi NF, Wasco W, et al. Characterization of the presenilin-binding protein calsenilin. Poster presented at Society for Neuroscience Annual Meeting, 1999

Fang Y, Choksi NY, Parvathy S, Yamin JJ, Wasco W, Buxbaum JD. Proteins interacting with the COOH-termini of the presenilins. Poster presented at Society for Neuroscience Annual Meeting, 1999.

Choksi NY, Mukherjeree P, Lindroth A, Xiang Z, Wasco W, Buxbaum JD, Pasinetti GM. Cyclooxygenase (COX)-2 expression is associated with presenilin-2 induced apoptosis. Poster presented at Society for Neuroscience Annual Meeting, 1999.

Gentry R, Clewell H, Gearhart J, Covington T, Andersen M. Development of a physiologically-based pharmacokinetic (PB-PK) model for isopropanol and acetone. Poster presented at the Society of Toxicology Annual Meeting, New Orleans, LA, March 1999.

Bogdanffy MS, Keller DA. 1999. Metabolism of xenobiotics by the respiratory tract. In: Gardener, DE (ed), Toxicology of the Lung, 3^rd ed., pp. 85–124. Taylor and Francis, Philadelphia, PA.

Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW Barone S, Choksi, NY, MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153:186–198; doi: 10.1006/taap.1998.8533.